A bone conduction solution may be the best option for patients with conductive hearing loss, mixed hearing loss or single-sided deafness. Our solutions include the Cochlear Osia® System and the Baha® System. Learn more below!
Welcome to Cochlear™ Quick Tips. The purpose behind Quick Tips is to give you “bite-sized” information that you can use when working with our products. In this edition, we will discuss how to […]
We recently interviewed Henrik Fyrlund, Manager of Advanced Acoustics and the Acoustics Portfolio Lead at Cochlear, to debunk some common myths about active bone conduction systems by discussing the science […]
Welcome to Cochlear™ Quick Tips. The purpose behind Quick Tips is to give you “bite-sized” information that you can use when working with our products. In this first edition, we […]
[LONE TREE, CO] – June 2, 2025: Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 Sound […]
The Cochlear™ Osia® System represents a significant advancement in bone conduction hearing technology. As we celebrate five years of innovation and over 25,000 systems in use worldwide, the Cochlear Osia […]
In the ever-evolving field of audiology, staying updated with the latest protocols and advancements is crucial. One such significant development is the Pediatric Bone Conduction Protocol, designed to enhance the evaluation […]
This year marks the 5-year anniversary of the Osia® System. As we celebrate this milestone, we spoke with the Global Product Managers at Cochlear’s Bone Conduction Headquarters in Gothenburg, Sweden, […]
Interviews with Dr. John Reinisch of Reinisch Plastic Surgery and Dr. Youssef Tahiri of Tahiri Plastic Surgery in Beverly Hills, California With the recent clearance in the US to lower […]
Introduced in December 2019, the Cochlear™ Osia® System has revolutionized clinical care and outcomes for patients with conductive hearing loss, mixed hearing loss and Single-Sided Deafness (SSD). Today, this innovative […]
Lone Tree, Colo. (April 19, 2024) – Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) clearance to lower the age […]
End of content
No more pages to load
